INTERIM UPDATE ON BASELINE CHARACTERISTICS AND EFFECTIVENESS FROM A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA) TREATED WITH FILGOTINIB (FILOSOPHY)

被引：1
|
作者：
Caporali, R. [1 ,2 ]
Avouac, J. [3 ]
Bevers, K. [4 ]
Burmester, G. R. [5 ]
Debray, T. [6 ]
De Leonardis, F. [7 ]
Harris, K. [8 ]
Betteridge, N. [9 ]
Romero-Yuste, S. [10 ]
Verschueren, P. [11 ,12 ]
Zignani, M. [7 ]
Galloway, J. [13 ]
机构：
[1] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[2] ASST Gaetano Pini CTO, Dept Rheumatol & Med Sci, Milan, Italy
[3] Univ Paris Cite, Hop Cochin, AP HP Ctr, Rheumatol Dept A, Paris, France
[4] Sint Maartenskliniek, Dept Rheumatol, Nijmegen, Netherlands
[5] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany
[6] Galapagos NV, Biostat, Mechelen, Belgium
[7] Galapagos GmbH, Med Affairs, Basel, Switzerland
[8] Galapagos NV, Med Affairs, Mechelen, Belgium
[9] Neil Betteridge Associates, London, England
[10] Univ Hosp Complex Pontevedra, Dept Rheumatol, Pontevedra, Spain
[11] Univ Hosp Leuven, Leuven, Belgium
[12] Katholieke Univ Leuven, Dept Rheumatol, Leuven, Belgium
[13] Kings Coll London, Ctr Rheumat Dis, London, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Rheumatoid arthritis; Real-world evidence; Patient reported; outcomes;
D O I：
10.1136/annrheumdis-2023-eular.1394
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0466
引用
收藏
页码：491 / 491
页数：1
相关论文
共 50 条
  • [1] SAFETY OUTCOMES IN PATIENTS (PTS) WITH RHEUMATOID ARTHRITIS (RA) TREATED WITH FILGOTINIB (FIL) IN FILOSOPHY: INTERIM RESULTS FROM A PROSPECTIVE OBSERVATIONAL STUDY
    Verschueren, P.
    Avouac, J.
    Bevers, K.
    Romero-Yuste, S.
    Caporali, R.
    Debray, T.
    De Leonardis, F.
    Galloway, J.
    Zignani, M.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1277 - 1277
  • [2] BASELINE CHARACTERISTICS OF AND EARLY OUTCOMES IN THE FIRST 200 PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH FILGOTINIB IN A PROSPECTIVE OBSERVATIONAL STUDY
    Galloway, James
    Bevers, Karen
    Verschueren, Patrick
    Caporali, Roberto
    Romero Yuste, Susana
    Avouac, Jerome
    Gvozdenovic, Emilia
    Harris, Kristina
    Zignani, Monia
    Burmester, Gerd
    RHEUMATOLOGY, 2023, 62
  • [3] Baseline Characteristics of and Early Outcomes in the First 200 Patients with RA Treated with Filgotinib in a Prospective Observational Study
    Galloway, James
    Bevers, Karen
    Verschueren, Patrick
    Caporali, Roberto Felice
    Yuste, Susana Romero
    Avouac, Jerome
    Gvozdenovic, Emilia
    Harris, Kristina
    Zignani, Monia
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 525 - 528
  • [4] PATIENT-REPORTED OUTCOMES, DISEASE ACTIVITY AND SAFETY IN UK PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH FILGOTINIB: UP TO SIX-MONTH INTERIM RESULTS FROM A PROSPECTIVE OBSERVATIONAL STUDY (FILOSOPHY)
    Kirkham, Bruce
    McKay, Neil D.
    Pratt, Arthur G.
    Barry, Jane
    Bouzid, Ouafia
    Debray, Thomas P. A.
    Bhat, Smita
    Robertson, Lindsay
    Galloway, James
    RHEUMATOLOGY, 2024, 63 : I82 - I83
  • [5] Patient-reported outcomes, disease activity and safety in UK patients with rheumatoid arthritis treated with filgotinib: up to six-month interim results from a prospective observational study (FILOSOPHY)
    Kirkham, Bruce
    Mckay, Neil D.
    Pratt, Arthur G.
    Barry, Jane
    Bouzid, Ouafia
    Debray, Thomas P. A.
    Bhat, Smita
    Robertson, Lindsay
    Galloway, James
    RHEUMATOLOGY, 2024, 63
  • [6] Patient-Reported Outcomes, Disease Activity and Safety in 798 Patients with RA Treated with Filgotinib: Up to 1-Year Interim Results from a Prospective Observational Study (FILOSOPHY)
    Burmester, Gerd
    Verschueren, Patrick
    Avouac, Jerome
    Caporali, Roberto F.
    Bevers, Karen
    Betteridge, Neil
    Debray, Thomas P. A.
    De Leonardis, Francesco
    Yuste, Susana Romero
    Zignani, Monia
    Galloway, James
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2611 - 2614
  • [7] BASELINE CHARACTERISTICS AND TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM RA-BE-REAL PROSPECTIVE OBSERVATIONAL STUDY
    Balsa, A.
    Favalli, E. G.
    Ikeda, K.
    van de Laar, M.
    Schulze-Koops, H.
    Haladyj, E.
    Fakhouri, W.
    Ogwu, S.
    Laedermann, C.
    Finckh., A.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [8] RADIUS: Interim findings from a prospective, multicenter, observational, outcomes study in rheumatoid arthritis (RA) patients.
    Cush, JJ
    Lautzenheiser, RL
    Markenson, JA
    Spencer-Green, G
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S528 - S529
  • [9] PATIENT-REPORTED OUTCOMES (PROs), DISEASE ACTIVITY AND SAFETY IN 1,177 PATIENTS WITH RHEUMATOID ARTHRITIS (RA)TREATED WITH FILGOTINIB FOR UPTO 18 MONTHS: INTERIM RESULTS FROM FILOSOPHY AND PARROTFISH
    Avouac, J.
    Burmester, G. R.
    Caporali, R. F.
    Debray, T. P. A.
    De Leonardis, F.
    Galloway, J.
    Betteridge, N.
    Bevers, K.
    Romero-Yuste, S.
    Zignani, M.
    Verschueren, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [10] Baseline Characteristics of Patients with Psoriatic Arthritis Treated with Ixekizumab or Interleukin-23 Inhibitors and Interim Effectiveness Results from an Observational Study in the US
    Oelke, Kurt
    Heredia, Emily Edson
    Ross, Sarah
    Lisse, Jeffrey
    Pustizzi, Jennifer
    Mehrabadi, Sheikhi
    Bello, Natalia
    Murphy, Frederick
    Singla, Shikha
    Raychaudhuri, Siba
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4757 - 4759
12345